Fiche publication
Date publication
juin 2026
Journal
PloS one
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BINQUET Christine
,
Pr HUET Frédéric
,
Pr FAIVRE Laurence
,
Pr THAUVIN-ROBINET Christel
,
Dr PEYRON Christine
Tous les auteurs :
Level C, Faivre L, Lemaitre M, Salvi D, Marchetti-Waternaux I, Cudry E, Simon E, Bourgon N, Benachi A, Van NT, Coppola C, Binquet C, Thauvin-Robinet C, Huet F, Peyron C
Lien Pubmed
Résumé
Newborn screening (NBS) has progressively expanded through technological innovations, from tandem mass spectrometry enabling expanded NBS (eNBS) to the prospect of genomic NBS (gNBS). While these developments promise earlier diagnosis and richer information, they also raise concerns regarding actionability, uncertainty, equity and psychosocial impact. As technological feasibility alone does not ensure public confidence, parental perspectives are central to evaluating future expansions. This study assessed parental views on NBS expansion in France, examining its determinants and whether genomics raises specific concerns.
Mots clés
Humans, Neonatal Screening, methods, France, Parents, psychology, Infant, Newborn, Female, Surveys and Questionnaires, Cross-Sectional Studies, Adult, Genomics, Male, Patient Acceptance of Health Care, psychology
Référence
PLoS One. 2026 06 15;21(6):e0343754
